Back to 
Blackstone Inc.
Blackstone Inc.
ARTV1 quarters
Position history for Blackstone Inc.'s holdings in ARTIVA BIOTHERAPEUTICS INC
Yes. Blackstone holds 2,403,437 shares of ARTV (Artiva Biotherapeutics), worth $23.3M, as of its Q2 2026 13F filing. It opened the position in Q2 2026. ARTV is 0.1% of Blackstone's reported 13F portfolio.
Current Value
$23.3M
Current Shares
2.4M
Total Value Change
$0
Total Shares Change
0
Quarter-by-Quarter History
Other major holders of ARTV: RA CAPITAL MANAGEMENT, L.P.